PCV9 COST-EFFECTIVENESS ANALYSIS OF ALTEPLASE COMPARED WITH STREPTOKINASE AND ABSENCE OF THROMBOLYTICAL THERAPY FOR MYOCARDIAL INFARCTION
Nov 1, 2004, 00:00
10.1016/S1098-3015(10)65791-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)65791-9/fulltext
Title :
PCV9 COST-EFFECTIVENESS ANALYSIS OF ALTEPLASE COMPARED WITH STREPTOKINASE AND ABSENCE OF THROMBOLYTICAL THERAPY FOR MYOCARDIAL INFARCTION
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65791-9&doi=10.1016/S1098-3015(10)65791-9
First page :
Section Title :
Open access? :
No
Section Order :
158